FDA head Robert Califf battles misinformation — sometimes with fuzzy facts

FHS
July 24, 2023
10:39 am

Robert Califf, the head of the Food and Drug Administration, doesn’t seem to be having fun on the job.

Ad Insights | Subcutaneous Cancer Immunotherapies Provide New Options for Physicians and Patients

One of the most meaningful shifts in the cancer treatment landscape has been the move toward therapies that not only fight the disease, but also

December 13, 2024

Risk adjusted net present value: What is the current valuation of Medivir’s Fostroxacitabine Bralpamide Hydrochloride?

Fostroxacitabine Bralpamide Hydrochloride is a small molecule commercialized by Medivir, with a leading Phase II program in Hepatocellular Carcinoma.

November 20, 2023

To mitigate drug shortages, a new study suggests looking at Canada

Of 104 reports of supply chain issues with dozens of drugs, meaningful shortages were 40% less likely to occur in Canada than in the U.S.,

October 31, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.